Dystrogen Therapeutics

Developing chimeric cell therapies for muscle wasting disorders like Duchenne Muscular Dystrophy

placeChicago, Illinois, United States calendar_todayFounded 2017 groups5 employees language dystrogen.com

Registered entities

Social engagement

Social engagement: 840 social following, 4 posts in the last 12 months — top 10% of its industry.

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%

Recent activity

2 Dec 2025
Milestone
regulatory
14 Jul 2025
Product launch
chimeric myoblasts (DT-DEC01)
Coming soon